SMJ Article | Original Article

Heart Disease Mortality on the Mississippi River

Objectives: States bordering the lower Mississippi River have large Black populations totaling 1,996,897. In 2019, 7506 Blacks there died of heart disease. These four states have high heart disease death rates. This analysis examined geographic variation in heart disease to suggest populations to target for intervention and suggest hypotheses for...

Posted in: Cardiovascular Disease31

SMJ Article | Original Article

Surgical Treatment of Cardiac Tumors: A Single-Center Experience

Objectives: Cardiac tumors affect fewer than 1 in 2000 people. This study is a retrospective review of diagnostic procedures, surgical management, and outcomes in patients treated for tumors of the heart at our institution. We compare our management approaches, clinical, and surgical outcomes with those reported in the literature. Methods:...

Posted in: Cardiac Tumors1

SMJ Article | Review Article

Role of hs-CRP in Post-MI Sequelae: Insights into Mechanisms and Clinical Significance

High-sensitivity C-reactive protein (hs-CRP) is a key marker of inflammation, predominantly produced by hepatocytes and various tissues, including intracardiac tissue, atherosclerotic plaques, and vascular smooth muscles. The biomarker serves as a crucial element of innate immunity and rises in response to various disease processes, including infections and cancers. This rise...

Posted in: Cardiovascular Disease31

SMJ Article | Original Article

Complementary and Alternative Medicine Use among Heart Failure Patients in the Deep South

Objective: Despite advancements in heart failure (HF) diagnostics and treatment, many palliative care patients with HF often seek complementary and alternative medicine (CAM) to improve quality of life and address unmet physical and emotional needs. This study aimed to explore the prevalence and patterns of CAM use among HF patients...

Posted in: Cardiovascular Disease31

SMJ Article | Review Article

The Moreton Lecture Series: The Renin-Angiotensin-Aldosterone System—Physiology, Pathophysiology, and Pharmacological Inhibition

The renin-angiotensin-aldosterone system (RAAS) is a complex regulator comprising hormones, proteins, and enzymes. The discovery of the RAAS and its pharmacological manipulation has been essential in the management of cardiovascular diseases, including hypertension. Beyond the benefits of hypertension, RAAS inhibition has implications for heart failure, atherosclerotic disease, and kidney disease....

Posted in: Hypertension10

SMJ Article | Original Article

Management of Pulmonary Embolism: A Single-Center Experience

Objective: Pulmonary embolism (PE) is the third leading cause of cardiovascular death. The objective of this study was to examine the current management of pulmonary embolism at a single academic institution. Methods: With institutional review board approval, we conducted a retrospective chart review of 805 encounters among 775 patients presenting...

Posted in: Cardiovascular Disease31

SMJ Article | Original Article

Improving Hypertension and Diabetes Mellitus Control with a Dedicated Patient Navigator

Objectives: Hypertension and diabetes mellitus (DM) are the leading causes of cardiovascular, cerebrovascular, and chronic kidney diseases. They affect an estimated 47% and 11% of Americans, respectively. In this study, we assessed whether a dedicated patient navigator embedded within a patient-centered medical home (PCMH) using a structured panel management and...

Posted in: Endocrinology, Diabetes, and Metabolism18 Hypertension10

SMJ Article | Original Article

A Curriculum on Advanced Topics in Hypertension for Internal Medicine Residents

Objectives: Hypertension (HTN) affects nearly half of US adults. Our multi-institutional survey revealed that Internal Medicine residents lack proficiency in advanced HTN topics. We developed a curriculum to address knowledge gaps in these topics and aimed to assess the effects of the curriculum on residents’ confidence, desire for future training,...

Posted in: Hypertension10

SMJ Article | Review Article

Elevated Lp(a): Guidance for Identifying and Managing Patients

Key Points Elevated lipoprotein(a) (Lp(a)) is considered an independent and causal risk factor for atherosclerotic cardiovascular disease (ASVCD) and calcific aortic valve disease, affecting approximately 20% of individuals. Lp(a) levels are established in youth and are almost exclusively genetic and minimally affected by nonpharmacologic interventions. Clinicians should suspect elevated Lp(a)...

Posted in: Cardiovascular Disease31

SMJ Article | Perspectives

White Coat Hypertension: A Benign Finding or a Masked Risk Factor?

A role of the primary care physician is to identify and manage patient risk factors. An easily identified risk factor is hypertension, especially considering its clear association with the development of various negative health outcomes. Studies have clearly demonstrated the benefits gained by the proper control of hypertension among patients,...

Posted in: Hypertension10

Load More Content

SMA Menu